Corvus Pharmaceuticals publishes final Phase 1 Soquelitinib data in Blood
Corvus Pharmaceuticals says final Phase 1 data from its Soquelitinib Phase 1/1b T cell lymphoma trial was published in Blood.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.